Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-19

Clinical Trial Update: Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial examining tranexamic acid to prevent hemorrhage during cesarean delivery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Post Partum Hemorrhage, Fibrinolysis; Hemorrhage | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-01-19